Endothelial dysfunction and immunothrombosis as key pathogenic mechanisms in COVID-19
Aldo BonaventuraFirst Clinic of Internal Medicine, Department of Internal Medicine, University of Genoa, Genoa, Italy. [email protected]Alessandra VecchiéDepartment of Internal Medicine, ASST dei Sette Laghi, Varese, ItalyLorenzo DagnaIstituto di Ricovero e Cura a Carattere Scientifico San RaffaeleKimberly MartinodCenter for Molecular and Vascular Biology, Department of Cardiovascular Sciences, KU Leuven, Leuven, BelgiumDave L. DixonDepartment of Pharmacotherapy and Outcome Science, School of Pharmacy, Virginia Commonwealth University, Richmond, VA, USABenjamín Van TassellDepartment of Pharmacotherapy and Outcome Science, School of Pharmacy, Virginia Commonwealth University, Richmond, VA, USAFrancesco DentaliDepartment of Medicine and Surgery, Insubria University, Varese, ItalyFabrizio MontecuccoIRCCS Ospedale Policlinico San Martino Genova - Italian Cardiovascular Network, Genoa, ItalySteffen MaßbergDeutsches Zentrum für Herz-Kreislauf-Forschung (DZHK) e.V., Partner Site Munich Heart Alliance, Munich, GermanyMarcel LeviDepartment of Medicine and Cardio-metabolic Programme — NIHR UCLH/UCL BRC, University College London Hospitals NHS Foundation Trust, London, UKAntonio AbbatePauley Heart Center, Division of Cardiology, Department of Internal Medicine, Virginia Commonwealth University, Richmond, VA, USA
2021en
ABI
Annotatsiya
Annotatsiya mavjud emas.
Identifikatorlar
Iqtiboslar va manbalar
3 ta iqtibos0 ta foydalanilgan manba